Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Main Authors: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Frontiers Media
2019
|
Registos relacionados
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
Por: Purvis, G, et al.
Publicado em: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Por: Zhibin Yan, et al.
Publicado em: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
Por: John, C, et al.
Publicado em: (2004) -
Annexin A1 in the brain--undiscovered roles?
Por: Solito, E, et al.
Publicado em: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
Por: Buckingham, J, et al.
Publicado em: (2006)